Today: 1 July 2026
McDonald’s stock today: MCD edges down as Fed minutes, year-end trade keep investors cautious
30 December 2025
2 mins read

McDonald’s stock today: MCD edges down as Fed minutes, year-end trade keep investors cautious

NEW YORK, December 30, 2025, 15:29 ET — Regular session

  • McDonald’s shares dipped 0.1% to $308.37 in late-afternoon New York trading.
  • The stock held up better than the consumer discretionary sector as year-end volumes stayed light.
  • Investors are watching Federal Reserve policy signals and the next earnings date estimate for early February.

McDonald’s Corp shares edged lower on Tuesday, trading at $308.37, down 0.05% in late-afternoon dealings.

The timing matters. With two sessions left in the year, trading volumes tend to thin out, and small shifts in positioning can move stocks more than usual, especially in defensive names investors use to park cash.

Portfolio managers also use the final week of December to trim big winners and rebalance exposure for January. “It’s just a healthy rebalancing of allocations more so than an emotionally driven sell-off,” said Mark Hackett, chief market strategist at Nationwide. Reuters

McDonald’s outperformed the broader consumer discretionary group, a pocket of the market that can swing with sentiment about jobs and household spending. The Consumer Discretionary Select Sector SPDR Fund fell about 0.4% while the S&P 500-tracking SPY ETF slipped about 0.1%.

Restaurant peers were mixed. Yum Brands rose 0.14%, while Restaurant Brands International fell 0.33% and Wendy’s was little changed.

Investors also parsed fresh signals from the Federal Reserve, after minutes from the central bank’s last meeting showed policymakers were split on how to balance inflation risks against signs of a cooling labor market. Benchmark 10-year Treasury yields ticked higher after the release, Reuters reported.

On the company front, McDonald’s has leaned into marketing and partnerships heading into 2026. A space-themed “Planet McDonald’s” Happy Meal tie-up with Crayola is rolling out in more than 60 countries, with availability varying by market through March 2026, trade publication MediaPost reported, citing a press release. MediaPost

The bigger near-term question for investors remains traffic and pricing power in the U.S., where restaurant operators have leaned on value offers to keep customers coming in. McDonald’s said in November that U.S. comparable sales — sales at restaurants open at least a year — rose 2.4% in the third quarter, as meal deals and promotions drew budget-conscious diners.

That playbook has a trade-off: discounts can lift visits but pressure margins if costs do not ease. Traders are watching whether McDonald’s can keep lower-income demand from weakening further without relying more heavily on promotions.

On Wall Street, analyst views remain cautious-to-neutral. MarketBeat’s compilation of recent ratings shows a consensus “Hold,” with an average 12-month price target of $324.57, implying mid-single-digit upside from current levels. MarketBeat

The next obvious catalyst is the company’s next quarterly report. McDonald’s has not confirmed a date, but MarketBeat estimates the next earnings release for Monday, Feb. 9, 2026, based on prior reporting patterns; the Fed’s next policy meeting is scheduled for Jan. 27–28.

For the rest of Tuesday’s session, traders kept an eye on technical markers after the stock traded between $306.84 and $308.60, with volume just over 1.0 million shares by mid-afternoon.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Phibro Animal Health (PAHC) tops Q1 expectations but stock sinks; pharma peers mixed
    July 1, 2026, 11:30 AM EDT. Phibro Animal Health (NASDAQ:PAHC) posted Q1 revenue of $383.5 million, up 10.3% from a year ago and ahead of analyst estimates by 8%. Still, shares of Phibro are down 44.6% since the report, last at $32.38. Across branded pharmaceuticals, sector revenue was 3.6% above forecasts with average share prices up 5% after earnings. Companies are pushing into precision medicine and AI drug development, but face hurdles like regulatory headwinds and patent cliffs. Eli Lilly (NYSE:LLY) was the top Q1 name, booking $19.8 billion in revenue, a 55.5% jump. Choppy moves and shifting strategies are keeping volatility high in pharma for now.
HFCL jumps 10% on heavy volumes even as MarketsMojo keeps “Strong Sell” callNEW YORK, December 29, 2025, 00:11 ET
Previous Story

HFCL jumps 10% on heavy volumes even as MarketsMojo keeps “Strong Sell” callNEW YORK, December 29, 2025, 00:11 ET

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next
Next Story

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next

Go toTop